Cholesterol-lowering medicines are taken by millions of people to reduce their risk of heart attacks and strokes. Recent ...

Docs were shocked that lowering Lp(a) didn’t slash heart risks. Here’s what to know.

Forbes contributors publish independent expert analyses and insights. Robert Glatter is a New York-based physician covering public health. This voice experience is generated by AI. Learn more. This ...

A new study has found that a cholesterol drug could lower heart attack risk in older adults. Here is how it can help and how ...

Merck has unveiled a new pill that slashes "bad" LDL cholesterol—by at least half in two-thirds of patients, per STAT News—opening the door to a future where heart attack and stroke risk could plummet ...

Add Yahoo as a preferred source to see more of our stories on Google. Reducing cholesterol levels might not just be good for your heart; they might also be effective at reducing your risk of dementia, ...

A nationwide Danish study of more than 132,000 people found a strong association between participants who took a popular ...

An experimental pill called enlicitide slashed levels of low-density lipoprotein (LDL) cholesterol, commonly known as "bad" cholesterol, by up to 60%, according to a new phase three clinical trial ...

A new kind of pill sharply reduced artery-clogging cholesterol in people who remain at high risk of heart attacks despite taking statins, researchers reported Wednesday. It’s still experimental but ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

MSD will announce the data at a future scientific congress. Image credit: HJBC / Shutterstock.com. · Pharmaceutical Technology · HJBC/Shutterstock.com. The above button links to Coinbase. Yahoo ...

Shares of Novartis fell more than 3% on Monday after its cholesterol drug failed in a closely watched study, dealing ‌a blow ...